Echavarría SMG, Franco LE, Juárez BA, Villanueva DCA

Language: Spanish
References: 16
Page: 241-246
PDF size: 151.00 Kb.

ABSTRACT

Introduction: The role of the series of metabolic derangements associated to diabetes mellitus type 2 on the function of the hypothalamicpituitary-testicular axis and on semen quality is still controversial due in part to the lack of information about the selection criteria of subjects included in previously published studies. This is important due to the high prevalence of occult pathology of the seminal tract.
Objective: To determine if diabetes mellitus type 2 is related to hormonal or seminal disorders.
Patients and methods: In this retrospective study serum concentration of the hormones that regulate the hypothalamic-pituitary-testicular axis and semen quality were analyzed comparatively in patients with diabetes mellitus type 2 and normoglycemic subjects. In both groups occult seminal disorders and conditions associated to the hypothalamic-pituitary-testicular axis dysfunction were discarded.
Results: Serum concentration of FSH was higher in patients with diabetes mellitus type 2 than in controls (6.06 ± 2.28 vs 4.74 ± 1.92, p = 0.04). Serum concentration of prolactin was lower in diabetics than in controls (6.71 ± 1.28 vs 8 ± 1.97, p = 0.002). The only seminal abnormality found in patients with diabetes mellitus type 2 was a lower progressive mobility (46.52 ± 17.77 vs 58.88 ± 16.81, p = 0.003).
Conclusion: This suggests that the patients with diabetes mellitus type 2 have subclinical tubular dysfunction manifested by a low sperm progressive mobility and that this might be associated to subfertility.

REFERENCES

1. Baker HWG, Burger HG, De Kretser DM, Hudson B. Relative incidence of etiological disorders of male infertility. In: Santen RJ, Swerdloff RS, editors. Male reproductive dysfunction: diagnosis and management of hypogonadism, infertility and impotence. New York: Marcel Decker, 1986;pp:341-72.

2. Salehi M, Bravo-Vera R, Sheikh A, Gouller A, Poretsky L. Pathogenesis of polycystic ovary syndrome: what is the role of obesity? Metabolism 2004;53(3):358-76.

3. Legro RS, Castracane VD, Kauffman RP. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv 2004;59(2):141-54.

4. Handelsman DJ, Conway AJ, Boylan LM, Yue DK, Turtle JR. Testicular function and glycemic control in diabetic men. A controlled study. Andrologia 1985;17(5):488-96.

5. Gwynne JT, Strauss JF III. The role of lipoproteins in steroidogenesis and cholesterol metabolism in steroidogenic glands. Endocr Rev 1982;3:299-329.

6. Fayrer-Hosken RA, Brackett BG, Brown J. Reversible inhibition of rabbit sperm-fertilizing ability by cholesterol sulphate. Biol Reprod 1987;36:878-83.�

7. Vignon F, Le Faou A, Montagnon D, et al. Comparative study of semen in diabetic and healthy men. Diabete Metab 1991; 17(3):350-4.

8. OMS. Manual de laboratorio de la Organización Mundial de la Salud para el examen de semen humano y de la interacción entre el semen y el moco cervical. Buenos Aires: Editorial Médica Panamericana, 1992.

9. Baccetti B, La Marca A, Piomboni P, et al. Insulin-dependent diabetes in men is associated with hypothalamo-pituitary derangement and with impairment in semen quality. Hum Reprod 2002;17(10):2673-7.

10. Lopez-Alvarenga JC, Zarinan T, Olivares A, et al. Poorly controlled type I diabetes mellitus in young men selectively suppresses luteinizing hormone secretory burst mass. J Clin Endocrinol Metab 2002;87(12):5507-15.

11. Ali ST, Shaikh RN, Ashfaqsiddiqi N, Siddiqi PQ. Serum and urinary levels of pituitary--gonadal hormones in insulin-dependent and non-insulin-dependent diabetic males with and without neuropathy. Arch Androl 1993;30(2):117-23.

12. Echavarría-Sánchez M, Barrón-González A, Torres-Martínez A, et al. Cambios en la reserva hipofisaria en relación al daño testicular. Perinatol Reprod Hum 1994;8:83-90.

13. Smith S, Wheeler MJ, Murray R, O’Keane V. The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic-pituitary-gonadal axis. J Clin Psychopharmacol 2002;22(2):109-14.

14. Ali ST, Shaikh RN, Siddiqi NA, Siddiqi PQ. Semen analysis in insulin-dependent/non-insulin-dependent diabetic men with/without neuropathy. Arch Androl 1993;30(1):47-54.

15. Padron RS, Mas J, Zamora R, et al. Lipids and testicular function. Int Urol Nephrol 1989;21(5):515-9.

16. Soler C, De Monserrat JJ, Gutierrez R, et al. Use of the spermclass analyser for objective assessment of human sperm morphology. Int J Androl 2003;26(5):262-70.